Veterinary Medicines Information website

Oridermyl ear gel

Authorised
  • NEOMYCIN SULFATE
  • Nystatin
  • Triamcinolone acetonide
  • Permethrin (25:75)

Product identification

Medicine name:
Oridermyl ear gel
Active substance:
  • NEOMYCIN SULFATE
  • Nystatin
  • Triamcinolone acetonide
  • Permethrin (25:75)
Target species:
  • Dog
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    4058.66
    international unit(s)
    /
    1.00
    gram(s)
  • Nystatin
    100000.00
    international unit(s)
    /
    1.00
    gram(s)
  • Triamcinolone acetonide
    1.00
    milligram(s)
    /
    1.00
    gram(s)
  • Permethrin (25:75)
    10.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Gel
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA04
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Aluminium tube of 10g with high-density polyethylene cap

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10521/026/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/06/2026
Download

ie-puar-np-600000064556-oridermyl-ear-gel-en.pdf

English (PDF)
Published on: 28/06/2026
Download